BLK BlackRock, Inc. Insider Trading

CEO Laurence Fink sold 1,905 shares of BlackRock at $1,080.57; stock now -12.1% from 52-week high, retains 223.8K shares

Laurence Fink, BlackRock's Chairman and CEO, disposed of 1,905 shares (0.8% of pre-transaction holdings) on 2026-07-16 at $1,080.57 per share, reducing his position from 225.7K shares to 223.8K shares. The sale occurred when the stock was trading -12.1% below its 52-week high of $1,219.94, and the current price of $1,072.20 is only marginally below the transaction price. Examination of his same-ticker history shows prior BLK sales on 2026-04-28 all exhibited negative 30-day returns (ranging -0.3% to -0.6%), with the most recent prior BLK sale (2025-07-25) delivering +0.0% at the 90-day mark—a single data point representing a miss for well-timed selling. His cross-ticker track record shows a 31.25% well-timed rate with an average 90-day return of +0.2% across 20 prior sells, indicating his sales have historically underperformed in capturing declines. The company remains fundamentally sound with FY revenue growth of +18.7%, net income of $2.2B on $6.7B quarterly revenue, and a P/E of 26.56, providing no obvious distress signal.

BlackRock CLO Christopher Meade sold 18,095 shares for $19,942,340.13 on 2026-07-16; retains 14,059 non-derivative shares post-sale.

Christopher J. Meade, General Counsel and CLO, executed 2 separate sales totaling 18,095 shares for $19,942,340.13 at a blended average price of $1,102.09. This represents a 56.3% reduction in non-derivative holdings, from 32,154 to 14,059 shares. Notably, Meade's cross-ticker track record shows a 100.00% well-timed rate on his prior 12 sells, with negative average 90-day returns of -6.9%; his prior 5 sales at BLK specifically were all well-timed at the 90-day mark, ranging from -2.0% to -2.8% post-trade. The current stock price of $1,072.20 is 12.1% below the 52-week high of $1,219.94 and 2.8% below the transaction prices (blended $1,102.09), suggesting the sale occurred near elevated valuations relative to recent trading ranges.

Fink sells 33,900 BLK shares for $35.6M at $1,050.55 blended avg; holds 230.5K post-transaction

Laurence Fink, BlackRock's Chairman and CEO, executed 4 separate sales totaling 33,900 shares for $35,613,716.65 on 2026-04-28, reducing his holdings by 12.8% to 230.5K shares. The blended average sale price of $1,050.55 sits 1.1% above the current price of $1,039.38 and reflects disciplined execution across multiple tranches. While Fink's cross-ticker track record shows a 25.00% well-timed sell rate with a positive 90-day average return of +4.6%, his prior BLK-specific trades show weaker timing: 4 of 5 prior sales returned positive at the 90-day mark, indicating the stock typically rose after those sales. The current filing arrives as BlackRock reports strong FY growth of +18.7%, net income of $1.3B on $6.5B quarterly revenue, and a P/E of 30.50—fundamental performance that suggests the sale reflects portfolio positioning rather than earnings-driven concern.

BlackRock President Robert Kapito sells $9.2M in shares amid stock pullback from recent highs.

BlackRock's President Robert Kapito executed a multi-tranche sale totaling approximately $9.2 million across three transactions, offloading roughly four percent of his holdings. The sales occurred as the stock pulled back from recent highs but remains elevated from the year's lows, and came after a strong recovery in the past month. BlackRock itself is financially robust—a highly profitable asset management giant generating strong revenue growth with earnings climbing, though the valuation reflects the market's premium on the business. Kapito's sale appears to be opportunistic profit-taking at an elevated price rather than a distress signal, particularly given the modest percentage of his total position being liquidated. Without additional context on his historical trading patterns or imminent material events, this filing suggests measured rebalancing by an executive rather than deep conviction about the company's near-term direction.

Kushel J. Richard sells 2,385 shares at $1,083.35 avg, retaining 61,980 shares; mixed timing at BLK vs cross-ticker record.

Kushel J. Richard, Senior Managing Director at BlackRock, executed two separate sales totaling 2,385 shares for $2,583,790.39 on 2026-02-24 at a blended average price of $1,083.35, reducing his holdings by 3.7% to 61,980 shares. The timing of this sale relative to his historical activity is ambiguous: his cross-ticker track record shows a 90-day well-timed rate of 35.29%, but at BlackRock specifically, none of his 4 prior measurable sales (between April and July 2025) were well-timed at the 90-day mark, each posting positive returns that suggest he sold before rallies. The current price of $1,090.27 sits 9.3% below the 52-week high, yet BlackRock's fundamentals remain robust with annual revenue growth of +18.7% and a P/E of 31.99. The sale falls within the insider's pattern of regular transactions at this ticker but lacks the pattern of forward-looking conviction evident in some prior executions.

Senior Managing Director Stephen Cohen sold 2,179 shares of BlackRock (BLK) for $2.3M at $1,073.87 on 2026-02-11

Stephen Cohen sold 2,179 shares representing a 25.0% reduction in his holdings, leaving him with 6,543 shares post-transaction. At the transaction price of $1,073.87, the stock was 10.9% below its 52-week high of $1,202.59. Historically, Cohen's cross-ticker track record shows 1 prior sell with a 90-day well-timed rate of 100.00%, and his single prior transaction at BlackRock on 2024-02-12 also exhibited negative 90-day returns (-1.1%), indicating that prior sales at this ticker preceded declines. The current price of $1,071.51 is only 0.2% below the transaction price, limiting any visible signal of forward-looking accuracy at this time. The sale occurs in a company generating $6.5B in quarterly revenue with 16.2% annual growth and a P/E of 27.23, maintaining strong fundamentals despite the elevated valuation.

COO Robert L. Goldstein sold 59,483 shares of BLK on Feb 10-11, 2026 for $64.7M; reduces stake 56.3%, continuing a pattern of well-timed exits.

Robert L. Goldstein, BlackRock's Chief Operating Officer, executed 13 separate sales totaling 59,483 shares for $64,658,976.76 across February 10–11, 2026, reducing his holdings from 105,668 shares to 46,185 shares—a 56.3% reduction of his pre-transaction stake. The blended average sale price of $1,087.02 sits near the 52-week high of $1,202.59, suggesting execution near relative strength. Goldstein's prior 5 trades at BLK (all sales on 2024-12-05) were uniformly well-timed at the 90-day mark, with negative returns ranging from -7.1% to -7.5%, and 100% of his same-ticker prior sales met that criterion. His cross-ticker track record over 10 prior sells shows a 90-day well-timed rate of 100.00%, with an average 90-day return of -7.5%. The current price ($1,055.63) is -12.2% from the 52-week high and down 3.1% over 30 days, placing recent action below the sale prices—a pattern consistent with his historical execution accuracy. Investors should note the substantial share reduction by an executive officer and its alignment with the insider's demonstrated track record of well-timed sell timing.

Kushel J. Richard sold 20,000 BLK shares at $1,125.00 on 2026-01-21 for $22.5M, reducing holdings by 24.4%

Kushel J. Richard, Senior Managing Director of BlackRock, executed a $22.5M sale of 20,000 shares at $1,125.00, reducing his post-transaction holdings to 61,894 shares from 81,894. The sale represents a significant 24.4% reduction in his holdings. Current price of $1,129.91 is 6.0% below the 52-week high, and the stock has gained 3.8% over the prior 30 days. Across his prior BLK sales, his timing has been mixed: his prior 5 trades at this ticker show 1 well-timed outcome at the 90-day mark, while his cross-ticker track record reflects a 35.29% well-timed rate on 17 prior sells. The sale occurs in a company with solid fundamentals—$6.5B in latest quarterly revenue, 16.2% annual revenue growth, and a P/E of 28.71—providing no obvious fundamental distress signal.

CFO Small Martin sold 27,047 shares of BLK for $31,675,812.92 on 2026-01-16, reducing holdings by 71.9%

Small Martin, BlackRock's CFO, executed 4 separate sales totaling 27,047 shares for $31,675,812.92 on a single day, reducing his post-transaction holdings to 10,557 shares from 37,604 shares (a 71.9% reduction). The blended average sale price of $1,171.14 sits 3.6% above the current price of $1,127.85 and 2.6% below the 52-week high of $1,202.59. Martin's prior sales at BLK show a 2-of-2 well-timed pattern at the 90-day horizon (both prior sales preceded subsequent declines), though his cross-ticker track record exhibits a 100% well-timed sell rate at 90 days. The substantial magnitude of this reduction—eliminating roughly three-quarters of prior holdings in a single filing—represents a material shift in insider position rather than routine portfolio activity.

Small Martin (CFO) sold 1,258 shares of BLK at $1,043.38; prior two BLK trades both well-timed with negative 90d returns.

CFO Small Martin sold 1,258 shares (16.8% of pre-transaction holdings) at $1,043.38 on 2025-12-01, reducing his stake to 6,209 shares. His prior trade history at BlackRock is notable: both previous sells in 2024 were well-timed against the 90-day mark, with 90-day returns of -3.7% and -3.8% respectively, demonstrating a pattern of selling ahead of subsequent declines. The stock is currently 10.2% below its 52-week high and showing a 90-day decline of -2.6%, consistent with the pattern from his prior transactions. Cross-ticker, Martin's track record shows a 100% well-timed rate on 2 prior sells, though this must be weighted against BlackRock's strong fundamentals: $6.5B in revenue, $1.3B net income, 16.2% annual revenue growth, and a 27.44 P/E ratio. The transaction itself does not appear to be driven by fundamental deterioration but rather reflects a historical pattern of well-timed exit timing at this ticker.